NOX — Noxopharm Share News
0.000.00%
Last trade - 00:00- AU$26.30m
- AU$30.46m
- AU$2.83m
Australia Stock Exchange release from NOXOPHARM : Retraction of Grant Announcement
Brief: Noxopharm Seeks Trading Halt
Australia Stock Exchange release from NOXOPHARM : Trading Halt
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:21:11
Australia Stock Exchange release from NOXOPHARM : Noxopharm Awarded A$8.8M Aust Govt Grant for Sarcoma Trial
Brief: Noxopharm Announces Darrt-2 Clinical Trial In U.S.
Australia Stock Exchange release from NOXOPHARM : DARRT-2 Trial Commences in the U.S.
Australia Stock Exchange release from NOXOPHARM : Unlisted Options Expiring on 30 November 2021
Australia Stock Exchange release from NOXOPHARM : Veyonda and Opdivo IONIC Study First Patient Dosed
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 08:45:27
Australia's Noxopharm rises chemotherapy patent in Australia, Europe
Australia Stock Exchange release from NOXOPHARM : Patent Granted for Veyonda and Low Dose Chemotherapy
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 11:08:09
Australia Stock Exchange release from NOXOPHARM : Jobkeeper s323DB Notice
Australia Stock Exchange release from NOXOPHARM : 2021 AGM Notice of Meeting and Proxy
Australia Stock Exchange release from NOXOPHARM : 2021 AGM Letter to Shareholders and Proxy
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:34:26
Australia Stock Exchange release from NOXOPHARM : September 2021 Quarterly Activities Report and Appendix 4C
Australia Stock Exchange release from NOXOPHARM : Cleansing Notice